Cor Vasa 2023, 65(2):236-286 | DOI: 10.33678/cor.2023.033
(2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG).
- a II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
- b Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno
- c I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc, Olomouc
- d I. interní kardioangiologická klinika, Lékařská fakulta v Hradci Králové Univerzity Karlovy a Fakultní nemocnice Hradec Králové, Hradec Králové
- e II. chirurgická klinika kardiovaskulární chirurgie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
Translation of the shortened document prepared by the Czech Society of Cardiology)
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group.
Keywords: balloon pulmonary angioplasty, chronic thrombo-embolic pulmonary hypertension, congenital heart disease, connective tissue disease, endothelin receptor antagonists, lung transplantation, pulmonary hypertension, guidelines, left heart disease, lung disease, phosphodiesterase type 5 inhibitors, prostacyclin analogues, prostacyclin receptor agonists, pulmonary arterial hypertension, pulmonary endarterectomy, soluble guanylate cyclase stimulators,
Received: April 14, 2023; Accepted: April 15, 2023; Published: May 1, 2023 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Originální verze je volně dostupná na https://academic.oup.com/eurheartj/article/43/38/3618/6673929?login=false a vyšla v časopise Eur Heart J 2022;43:3618-3731. doi: 10.1093/eurheartj/ehac237.
Go to original source... 
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.